Hola,
Are you new here?

I have an account

Conecta con

+150K Projects

+300K Companies

+230 Financiaciones

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

ADAPTED

financed

Closed

Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Develo...

Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development Sofia ref. 115975 APOEɛ4 has long been known as a risk factor of LOAD, yet the biological mechanisms through which it acts remain largely unknown and affect both the vasculature and the brain. This complexity and pleiotropic influence demands an in... see more

30/09/2020

FUNDACIO ACE INSTI...

7M€

Project Budget: 7M€

Project leader

FUNDACIO ACE INSTITUT CATALA DE NEUROCIENCIES... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 130K€

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 14 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2020-09-30

IMI2-2015-05-06: From ApoE biology to validated Alzh... Specific Challenge:Apolipoprotein E ε4 (ApoE4) is the most prominent Alzheimer’s Disease (AD) suscep...

I+D

Cerrada does 9 years

0% 52% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

14 Participantes

FUNDACIO ACE INSTITUT CATALA...

333.76K€ | Leader

ERASMUS MC

420.50K€ | participant

JANSSEN PHARMACEUTICA NV

750.00K€ | participant

MIMETAS

305.10K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 46 months Date Start: 2016-11-09
End date: 2020-09-30

Project leader

FUNDACIO ACE INSTITUT CATALA DE NEUROCIENCIES... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 130K€

Project Budget 7M€

participation deadline Sin fecha límite de participación.

Project description APOEɛ4 has long been known as a risk factor of LOAD, yet the biological mechanisms through which it acts remain largely unknown and affect both the vasculature and the brain. This complexity and pleiotropic influence demands an integrated hypothesis-free approach to embark on a fundamental study of the gene, the phenotype and modulation by other risk factors. ADAPTED proposes to leverage extreme genotypes from consortium cohorts dating back more than 25 years to generate, and use existing, lines of human induced pluripotent stem cells (iPSC). These cells, with blood cells, will form the backbone of the research programme. We will differentiate them to the most relevant cells for APOE and AD studies and with gene editing create bespoke homozygote ɛ3 and ɛ2 cells for a highly focussed effort on APOE biology. A series of experiments including neuron-astrocyte and macrophage-endothelium co-culture and Organ on a Chip models combined with state-of-the-art omics including quantitative proteomics assays will generate data for rigorous integrated analysis to uncover new signalling pathways related to APOE. Lipid homeostasis, endocytosis, metabolism and immune systems pathways will be investigated in a broad approach. The findings are expected to lead to identification of new treatment approaches and blood based AD signatures with a temporal dimension from the earliest stages of risk identification and progression through MCI to AD. Testing and validation of biomarkers will be performed by examining their influence and predictive capacity in a longitudinal ADAPTED cohort harmonised using a combination of approaches for marker and diagnostic consistency. The impact of this work can be expected to include seminal new finding to illuminate the research path towards new diagnostics and therapies to attenuate the rising tide of suffering from AD. The vision is a follow on with clinical proof of concept validating utility of the results within two years of the end of ADAPTED.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers

What is innovating.Works? Lose yourself in the best search engine for innovative companies you've ever seen, see how your competition is funded, connect with that partner you didn't know about, discover R&D projects that need you, and much, much more just a click away.

Smart Company-Financial Motor Innovating tiene un perfil tecnológico financiero de 400.000 empresas gracias al cual sabe a qué ayuda puede ir o no cualquier empresa de forma automática. Parece magia pero es tecnología.

Create your project and find partners ¿Tienes un proyecto y buscas un partner? Una Universidad, Centro Tecnológico, Consultoría? Este es tu sitio. Gracias al motor de búsqueda podemos recomendarte los mejores socios y ponerte en contacto con ellos.